Curative effect and prognosis analysis of lung transplantation for patients over 65 years old with end-stage lung diseases
-
摘要:
目的 探讨65岁以上终末期肺病患者肺移植的疗效及预后。 方法 回顾性分析2002年9月至2011年12月南京医科大学附属无锡市人民医院收治的24例老年(≥65岁)肺移植病例的临床资料。了解老年肺移植患者的存活情况, 比较单肺和双肺移植的存活情况; 了解肺移植术后并发症及对随访期内死亡的病例进行死因分析。 结果 所有患者肺移植手术均顺利完成。24例受者术后1、3、5、7年累积存活率分别为75.0%、62.5%、33.3%和12.5%, 其中单肺移植患者相应为68.8%、50.0%、31.3%和12.5%, 双肺移植患者相应为87.5%、87.5%、37.5%和12.5%。单肺与双肺移植患者中位生存时间分别为35、51个月, 两组生存期比较差异无统计学意义(P>0.05)。感染是术后最主要的并发症, 发生率为46%(11/24)。术后长期随访中17例死亡, 包括重症感染9例, 原发性移植物失功(PGD)1例, 急性排斥反应(AR)1例, 闭塞性细支气管炎(BOS)4例, 心力衰竭1例, 肿瘤1例。 结论 单肺或双肺移植均是治疗老年终末期肺病的有效方法, 感染是老年受者术后最主要的并发症和死亡原因。 Abstract:Objective To investigate the curative effect and prognosis of lung transplantation for patients over 65 years old with end-stage lung diseases. Methods Clinical data of 24 elderly patients (≥65 years old) undergoing lung transplantation in Affiliated Wuxi People's Hospital of Nanjing Medical University from September 2002 to December 2011 were retrospectively analyzed. The survival conditions of elderly patients undergoing lung transplantation were studied and the survival conditions of unilateral lung transplantation and bilateral lung transplantation were compared. The complications after lung transplantation were observed and the death causes of patients died during the follow-up period was analyzed. Results All patients completed the lung transplantation successfully. The 1, 3, 5 and 7-year cumulative survival rate of the 24 patients were respectively 75.0%, 62.5%, 33.3% and 12.5%, and those of patients undergoing unilateral lung transplantation were respectively 68.8%, 50.0%, 31.3% and 12.5% and those of the patients undergoing bilateral lung transplantation were respectively 87.5%, 87.5%, 37.5% and 12.5%. The median survival time of the patients undergoing unilateral lung transplantation and bilateral lung transplantation was respectively 35 months and 51 months, and there was no significant difference (P>0.05). The primary postoperative complication was infection with the incidence of 46% (11/24). Seventeen patients died during the long-term follow-up. Among them, 9 died of severe infection, 1 died of primary graft dysfunction (PGD), 1 died of acute rejection (AR), 4 died of bronchiolitis obliterans syndrome (BOS), 1 died of heart failure and 1 died of tumor. Conclusions Unilateral lung transplantation and bilateral lung transplantation are both effective methods to treat elderly patients with end-stage lung diseases. Infection is the primary postoperative complication and the cause of death of elderly patients. -
Key words:
- Lung transplantation /
- End-stage lung disease /
- Elderly /
- Infection /
- Prognosis
-
表 1 单肺移植与双肺移植老年患者的术前临床资料比较
Table 1. Comparison of preoperative clinical data of elderly patients receiving unilateral or bilateral lung transplantation
项目 单肺移植
(n=16)双肺移植
(n=8)P值 年龄[岁,(x±s)] 69.5±3.3 65.3±3.9 0.319 性别[男/女,n/n] 10/6 4/4 0.439 体重指数(kg/m2) 20.9±3.3 21.8±2.5 0.192 诊断(n) IPF 10 6 0.57 COPD 4 2 其他 2 0 呼吸机依赖(n) 10 2 0.097 MPAP≥30 mmHg(n) 12 6 0.698 NYHA心功能分级(n) Ⅰ~Ⅱ级 0 0 0.221 Ⅲ级 4 4 Ⅳ级 12 4 使用ECMO(n) 4 6 0.028 ICU停留时间[d,(x±s)] 6.4±3.7 8.2±2.5 0.071 住院时间[d,(x±s)] 52±7 65±9 0.124 有并发症(n) 10 3 0.235 注:ECMO为体外膜肺氧合 表 2 单肺与双肺移植患者术后并发症比较
Table 2. Comparison of postoperative complications of patients between unilateral lung transplantation and bilateral lung transplantation
术后并发症 单肺移植
(n=16)双肺移植
(n=8)P值 重症感染 7 4 0.556 PGD 2 1 0.723 AR 1 0 0.667 BOS 5 3 0.553 出血 1 0 0.667 吻合口并发症 1 0 0.667 糖尿病 3 2 0.555 其他 3 2 0.555 -
[1] 李慧星, 毛文君, 陈静瑜, 等.肺叶切除术治疗双肺移植术后肺不张疗效分析[J].器官移植, 2014, 5(1):24-27, 31. http://www.organtranspl.com/browse/detail/qkid/84/id/237.htmlLi HX, Mao WJ, Chen JY, et al. Analysis of curative effect of pulmonary lobectomy on atelectasis after lung transplantation[J]. Organ Transplant, 2014, 5(1):24-27, 31. http://www.organtranspl.com/browse/detail/qkid/84/id/237.html [2] 徐海英, 毛文君, 陈静瑜, 等.公民逝世后器官捐献供肺的评估及获取经验19例报告[J].中华器官移植杂志, 2014, 35(7):396-400. doi: 10.3760/cma.j.issn.0254-1785.2014.07.004Xu HY, Mao WJ, Chen JY, et al. Experience of donation after citizens death for lung transplant: report of 19 cases[J]. Chin J Organ Transplant, 2014, 35(7):396-400. doi: 10.3760/cma.j.issn.0254-1785.2014.07.004 [3] Yusen RD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report:2014; focus theme: retransplantation[J]. J Heart Lung Transplant, 2014, 33(10):1009-1024. doi: 10.1016/j.healun.2014.08.004 [4] Yusen RD, Christie JD, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report:2013;focus theme: age[J]. J Heart Lung Transplant, 2013, 32(10):965-978. doi: 10.1016/j.healun.2013.08.007 [5] Fildes JE, Archer LD, Blaikley J, et al. Clinical outcome of patients transplanted with marginal donor lungs via ex vivo lung perfusion compared to standard lung transplantation[J]. Transplantation, 2015, 99(5):1078-1083. doi: 10.1097/TP.0000000000000462 [6] Kreider M, Kotloff RM. Selection of candidates for lung transplantation[J]. Proc Am Thorac Soc, 2009, 6(1):20-27. doi: 10.1513/pats.200808-097GO [7] Mahidhara R, Bastani S, Ross DJ, et al. Lung transplantation in older patients?[J]. J Thorac Cardiovasc Surg, 2008, 135(2):412-420. doi: 10.1016/j.jtcvs.2007.09.030 [8] Machuca TN, Camargo SM, Schio SM, et al. Lung transplantation for patients older than 65 years: is it a feasible option?[J]. Transplant Proc, 2011, 43(1):233-235. doi: 10.1016/j.transproceed.2010.12.010 [9] Weiss ES, Merlo CA, Shah AS. Impact of advanced age in lung transplantation: an analysis of United Network for Organ Sharing data[J]. J Am Coll Surg, 2009, 208(3):400-409. doi: 10.1016/j.jamcollsurg.2008.12.010 [10] Machuzak M, Santacruz JF, Gildea T, et al. Airway complications after lung transplantation[J]. Thorac Surg Clin, 2015, 25(1):55-75. doi: 10.1016/j.thorsurg.2014.09.008 [11] Gutierrez C, Al-Faifi S, Chaparro C, et al. The effect of recipient's age on lung transplant outcome[J]. Am J Transplant, 2007, 7(5):1271-1277. doi: 10.1111/ajt.2007.7.issue-5 [12] Riera J, Caralt B, López I, et al. Ventilator-associated respiratory infection following lung transplantation[J]. Eur Respir J, 2015, 45(3):726-737. doi: 10.1183/09031936.00095214 [13] Dorgan DJ, Hadjiliadis D. Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities[J]. Expert Rev Respir Med, 2014, 8(3):315-326. doi: 10.1586/17476348.2014.899906 [14] 张晓峰, 陈国千, 吴国荣, 等.肺移植受者血清可溶性白细胞介素-2受体检测的临床应用[J].实用医学杂志, 2012, 28(20):3463-3464. http://www.cqvip.com/qk/93362x/201220/43685189.htmlZhang XF, Chen GQ, Wu GR, et al. Clinical application of detection of serum soluble interleukin-2 receptor of lung transplant recipients[J]. J Pract Med, 2012, 28(20):3463-3464. http://www.cqvip.com/qk/93362x/201220/43685189.html [15] Patel N, Snyder LD, Finlen-Copeland A, et al. Is prevention the best treatment? CMV after lung transplantation[J]. Am J Transplant, 2012, 12(3):539-544. doi: 10.1111/j.1600-6143.2011.03837.x [16] Hayes D Jr, Weiland A, Kirkby S, et al. Gram-negative infection and bronchiectasis in lung transplant recipients with bronchiolitis obliterans syndrome[J]. Thorac Cardiovasc Surg, 2013, 61(3):240-245. http://cn.bing.com/academic/profile?id=2023779572&encoded=0&v=paper_preview&mkt=zh-cn [17] Hayes D Jr, Mansour HM, Kirkby S, et al. Rapid acute onset of bronchiolitis obliterans syndrome in a lung transplant recipient after respiratory syncytial virus infection[J]. Transpl Infect Dis, 2012, 14(5):548-550. doi: 10.1111/tid.2012.14.issue-5 [18] Ghassemieh B, Ahya VN, Baz MA, et al. Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation[J]. J Heart Lung Transplant, 2013, 32(7):701-706. doi: 10.1016/j.healun.2013.04.010 [19] Kim SY, Shin JA, Cho EN, et al. Late respiratory infection after lung transplantation[J]. Tuberc Respir Dis, 2013, 74(2):63-69. doi: 10.4046/trd.2013.74.2.63